Pb2+: An endocrine disruptor in Drosophila?

Pb2+: An endocrine disruptor in Drosophila?

Physiology & Behavior 99 (2010) 254–259 Contents lists available at ScienceDirect Physiology & Behavior j o u r n a l h o m e p a g e : w w w. e l s...

212KB Sizes 13 Downloads 138 Views

Physiology & Behavior 99 (2010) 254–259

Contents lists available at ScienceDirect

Physiology & Behavior j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / p h b

Pb2+: An endocrine disruptor in Drosophila? Helmut V.B. Hirsch a,⁎, Debra Possidente b,1, Bernard Possidente b,1 a b

Department of Biological Sciences, The University at Albany, SUNY, 1400 Washington Avenue, Albany, NY 12222, USA Department of Biology, Skidmore College, Saratoga Springs, NY 12866, USA

a r t i c l e

i n f o

Article history: Received 28 May 2009 Received in revised form 10 September 2009 Accepted 17 September 2009 Keywords: Endocrine disruptor Pb2+ Drosophila Neural development Synaptic function Model systems

a b s t r a c t Environmental exposure to Pb2+ affects hormone-mediated responses in vertebrates. To help establish the fruit fly, Drosophila melanogaster, as a model system for studying such disruption, we describe effects of Pb2+ on hormonally regulated traits. These include duration of development, longevity, females' willingness to mate, fecundity and adult locomotor activity. Developmental Pb2+ exposure has been shown to affect gene expression in a specific region of the Drosophila genome (~122 genes) involved in lead-induced changes in adult locomotion and to affect regulation of intracellular calcium levels associated with neuronal activity at identified synapses in the larval neuromuscular junction. We suggest ways in which Drosophila could become a new model system for the study of endocrine disruptors at genetic, neural and behavioral levels of analysis, particularly by use of genomic methods. This will facilitate efforts to distinguish between behavioral effects of Pb2+ caused by direct action on neural mechanisms versus effects of Pb+ 2 on behavior mediated through endocrine disruption. © 2009 Elsevier Inc. All rights reserved.

1. Introduction The toxicity of the heavy metal Pb2+ has been recognized for some 4000 years; nevertheless, its use increased dramatically from the beginning of the twentieth century, especially with the introduction of leaded gasoline [1], and Pb2+ is now ubiquitous in the biosphere [1,2]. Although the phase-out of leaded paint and gasoline in the 1980s produced a drop in blood lead levels in the United States population as a whole [3,4], Pb2+ exposure remains a significant public health problem [5–7] because children continue to be exposed to lead-contaminated paint [3,8,9] and soil [10,11]. Furthermore, in some countries lead-based paint is still being manufactured and sold [12,13], while industries such as e-waste recycling introduce new sources of contamination [14]. Furthermore, many adults carry Pb2+ in their skeletons [15–19] which affects their cognitive function [19,20], cardiovascular health [20,21], and renal function [20], and can be mobilized and passed on to fetuses or infants [22]. The bulk of the research on effects of chronic developmental exposure of children to Pb2+ has focused on deficits in cognitive ability [4,23–29], increases in delinquency [30–32] and in behaviors associated with Attention Deficit Hyperactivity Disorder [33], changes in activity [34] and possibly altered sensory function [35–40]. It is likely that these Pb2+-dependent effects involve synaptic changes (e.g. muscarinic modulation [41–43], changes in N-methyl-D-aspar⁎ Corresponding author. Tel.: +1 518 442 4311; fax: +1 518 442 4767. E-mail addresses: [email protected] (H.V.B. Hirsch), [email protected] (D. Possidente), [email protected] (B. Possidente). 1 Tel.: +1 518 580 5082; fax: +1 518 580 5071. 0031-9384/$ – see front matter © 2009 Elsevier Inc. All rights reserved. doi:10.1016/j.physbeh.2009.09.014

tate receptor function [6,44,45], effects on voltage-gated sodium channels [46] and changes in calcium signaling), which have been shown both in vertebrates [47–52] and at identified synapses at the neuromuscular junction in third instar Drosophila larvae [53]. A second, much smaller, focus has been on Pb2+-dependent delays in the onset of sexual maturity in girls [54–57] (but see also [58]) and on reductions in testicular volume in boys [56]; acute Pb2+ exposure can also affect reproductive function in both women [59] and men [60–63]. Thus, not only does Pb2+ have direct effects on neuronal development and function, it may also have indirect ones by acting as an endocrine disruptor. Estrogens serve vital functions in brain development, affecting not only the establishment of sex differences but also acting as trophic and neuroprotective agents [64–67]. Furthermore, brain levels of estradiol, estradiol synthase and estrogen receptors are all at their peaks prenatally or during the first few days of life [65], the same period in which the majority of synaptic connections develop in the brain [68]. This raises the question of whether Pb2+ acts directly on synaptic development [53,69–71], and/or whether Pb2+-dependent synaptic effects are mediated through changes in endocrine function. What is missing are studies that look at both “cognitive” and “endocrine disruptive” effects of chronic developmental Pb2+ exposure [72], for example looking at the concurrent effects of developmental Pb2+ exposure on timing of sexual maturity, sexual function and cognitive function. Recent reviews summarize both the scope of the problem and progress made in understanding the mechanisms by which endocrine disruptors affect growth and development [73–77]. The majority of this work has focused on endocrine disruptor effects in humans or in

H.V.B. Hirsch et al. / Physiology & Behavior 99 (2010) 254–259

rodents, although there is comparable evidence for birds, reptiles, fish and aquatic invertebrates as well (for reviews see [75,76]). As Iavicoli et al. [78] note, Pb2+ affects multiple cellular functions and endocrine mechanisms, including multiple effects on the hypothalamus– pituitary–gonadal axis, altered onset of puberty in humans and rodents, altered estrogen and LH receptor affinity, lowered serum levels of IGF-1, testosterone and estradiol, altered sperm morphology and function, inhibition of GH synthesis and LH secretion, reduced expression of the steroidogenic acute regulatory protein (StAR), increased lipid peroxidation in seminal plasma and increased production of reactive oxygen species (ROS). In this paper we summarize evidence that Drosophila, which has already shown itself to be an overlooked yet very powerful model system for the study of such neurotoxins as Pb2+ [53,70,79–81], Zn2+[82], Cd2+ [83–85] and Hg2+ [86], may also be an excellent system for studying endocrine disruptors. 2. Drosophila endocrinology Insects have true endocrine glands that are derived from epithelial tissue and that function in much the same way as vertebrate glands [87,88]. There are both circulating hormones and nuclear receptors (NRs), much like those in vertebrates [89]. The Drosophila genome codes for NRs that represent all major subclasses of human receptors and includes orthologs of key human NRs [89]. Two major hormonal systems in Drosophila involve Ecdysone (Ecy), which is a steroid, and Juvenile Hormone (JH), a sesquiterpinoid. Ecy is produced in the prothoracic glands, while JH is produced in the corpora allata in the brain [88]. The ecdysteroids of Drosophila are homologous to the cholesterol-derived steroid hormones such as estradiol, and JH shares some characteristics with retinoic acid (Fig. 1). Comparing 18 known Drosophila hormone NRs with 48 NRs identified in humans gives 16 orthologs, covering all 6 NR superfamily subtypes, including many for steroid NRs, and two for retinoic acid NRs [90]. At least 8 of the 16 human-ortholog NRs are known to be regulated by Ecy, however the one receptor known to use Ecy as a ligand (Ecdysone Receptor, or EcR), also uses the retinoic acid NR homolog (USP) in the ligand's heterodimer [87]. The EcR–USP dimer continues the signaling cascade to turn on the seven other NRs, which together control the processes of gastrulation, embryonic segmentation, oogenesis, and larval polytene chromosome puffing [90], as well as modulation of three essential molecules, alcohol dehydrogenase, urate oxidase, and glucose dehydrogenase [88]. Each peak of Ecy precedes and controls a molt. At the end of the third larval instar, JH stops being produced, and this allows the peak in Ecy to initiate pupation, massive cell death, the development of adult

255

structure from the imaginal discs, and head eversion [88]. JH returns in the adult stage and regulates spermatogenesis [88], life-span [91,92], sex differences in locomotor behavior [92,93] and feeding behavior [94], as well as intensity of courtship [92,95], interacting with Ecy to promote fertility [90]. Understanding the regulation of development by Drosophila hormones and their 16 human-orthologous NRs should help elucidate control of human hormone–NR systems [96–103]. 2.1. Pb2+ effects on hormonally regulated behavior in Drosophila Chronic developmental exposure of Drosophila to Pb2+, even at low doses, affects a number of behaviors that are hormone-mediated. These include developmental delays following acute exposure (rearing Drosophila during preadult stages on medium containing 100– 2500 ppm Pb2+ increases the time to pupation [83,104,105]), and shortening in preadult development after many generations of exposure to high levels of Pb2+ [104]. Exposure to high doses of Pb2+ (2070 ppm) decreases life-span [106] while low doses (0.207–2.07 ppm) have no significant effect. As may be the case in mice [78], when Drosophila are reared from egg stages to adult days 5–7 on medium made with very low doses of Pb2+ (2–8 ppm), females are more willing to mate than controls (reared on medium made with distilled water), while exposure over the same interval to somewhat higher doses (20–50 ppm) reduces females' willingness to mate [79]. Fecundity (the number of viable offspring per female) is increased by exposure to low loses (2 ppm, again from egg stages to adult days 5–7) [79], while exposure to a range of higher doses (20 ppm [79] and 100–500 ppm [105]) does not appear to affect fecundity; at even higher doses (500–50,000 ppm) fecundity is reduced [107]. Finally, locomotor activity of adults (the distance travelled in a set interval of time) is reduced by exposure to Pb2+, but only at higher doses (50 ppm; the change is significant only for males [79]). As in vertebrates, the underlying mechanisms are poorly understood, and Drosophila provide another model system for investigating them. Note that for females' willingness to mate and fecundity the dose response curves are biphasic, that is, hormetic [108]. Furthermore, in Drosophila third instar larvae, chronic Pb2+ exposure modifies development of individual, identifiable synapses between motorneurons and the muscle fibers they innervate [70]. At the same larval synapses Pb2+ exposure also increases intracellular calcium levels and synaptic facilitation; most likely this is due to Pb2+-dependent reduction in the activity of the plasma membrane Ca2+ ATPase (PMCA), which extrudes Ca2+ from these synaptic terminals [53]. We have recently identified, by QTL analysis [109], a region (30AB) of the Drosophila second chromosome that mediates a Pb2+dependent change in locomotor behavior [80]. This region is also known to control the expression of cis and trans downstream genes in

Fig. 1. Human estradiol compared to insect ecdysone, and human retinoic acid compared to insect juvenile hormone.

256

H.V.B. Hirsch et al. / Physiology & Behavior 99 (2010) 254–259

response to Pb2+ [81]. Genes in 30AB are therefore candidate genes for study of this gene expression-to-behavior link. We have focused on 122 genes extending through 30AB and half-way through the adjoining cytological regions (because of the low resolution of this technique relative to a single locus) for further analysis. Based on known gene functions and on an unbiased correlation of lead-induced changes in gene expression [81] with Pb2+-induced changes in behavior [80] we have identified a subset of these as candidate loci for the QTL. Drosophila are thus a useful model for studying behavioral, synaptic and genetic changes following chronic exposure to the neurotoxin Pb2+. 3. Pb2+ toxicity mediated by oxidative stress PbAc causes oxidative stress by direct conjugation with glutathione (GSH), a tripeptide in mM concentrations in cells that buffers against oxidative stress by forming covalent adducts with oxidized proteins and lipids. PbAc has also been proposed to induce oxidative stress by inhibiting sulfhydryl-dependent enzymes, interfering with other metals needed for antioxidant enzyme activities, and by causing the oxidation of lipids and interfering with membrane integrity and fatty acid composition (reviewed in [110]). In 1965, E.D. Wills published the first paper linking PbAc toxicity to oxidative stress, and demonstrated that lead and other metals catalyze the oxidation of unsaturated fatty acids [111]. More recently, in 1995, Yiin and Lin demonstrated that PbAc enhances oxidation of linoic, linoleic, and arachidonic acids [112]. Several other studies have demonstrated elevated lipid peroxidation or decreased antioxidant defense in tissues of PbAc exposed animals [113–116]. Because of the possibility that many of the toxic effects of PbAc are mediated by oxidative stress, Gurer and Ercal have recently proposed that antioxidants might be beneficial in the treatment of lead poisoning combined with CaNa2EGTA or succimer, the most commonly used chelating agents [110]. Any system that depends on glutathione control of oxidative stress (such as solubility of toxins, heme regulation, insecticide resistance, stress signal transduction, membrane integrity, and egg size and shape) can be studied in lead-treated Drosophila. For example, regulation of circadian rhythms by one of Drosophila's NRs (E75) has recently been suggested by the finding of a heme group in its ligand-binding domain, which should confer the ability to attract small gas molecules such as NO and CO, known to function in stress– response pathways and circadian rhythm regulation [99,102]. 4. Advantages of Drosophila for genetic analysis of lead toxicity Certainly, Drosophila can be a useful system for the genetic analysis of endocrine disruptors and their mechanisms. Advantages of Drosophila as a model system in this field include a short life cycle, economy, efficiency and a long history of research with an extensive literature as well as a full complement of genetic and genomic methods (see the FlyBase web server (http://flybase.org/) and [117] for a comprehensive genetic and genomic database on Drosophila, and the Drosophila Information Service (http://www.ou.edu/journals/dis/) for a rich database of Drosophila research and technical publications). Genetic tools available in Drosophila include (1) the existence of many mutants (e.g. Ecdysoneless [118] and Methoprene-tolerant [95]); (2) transgenic constructs in which mammalian genes are inserted into flies (e.g. [103]); and (3) quantitative trait locus mapping that allows genetic variation affecting complex traits to be mapped to specific regions of the genome [80,119–121]. Drosophila have proven to be a useful genetic model, in combination with mammalian models, for successful analysis of such complex traits as circadian rhythmicity [122] including circadian modulation of susceptibility to pesticides [123]. These approaches, combined with the most current genetic methods for analysis of complex traits [119,120,122,124–126] can facilitate efficient screening of known hormone disruptors, and

comprehensive analysis of their genetic, neural and behavioral mechanisms of action. Thackray et al. [103] have constructed transgenic Drosophila with the human estrogen receptor alpha and an estrogen responsive green fluorescent reporter gene and demonstrated a response to estrogen compounds in the food. This system has not yet been used to examine potential effects of lead on human estrogen receptor function. A Drosophila-derived cell culture assay for direct effects of ecdysteroids and their agonists and antagonists also has yet to be employed to investigate direct effects of lead as an endocrine disruptor [127]. Drosophila are also relatively amenable to genetic manipulations of target phenotypes relevant to endocrine disruption by methods such as artificial selection that would be arduous and expensive to apply even to rodent animal models. Magnusson and Ramel [128], for example, showed that genetic differences in tolerance to toxic metals including lead was genetically variable among strains, with little correlation between patterns of strain differences across different metals. They were also able to increase tolerance to mercury compounds, specifically, by 12 generations of artificial selection from a base population of four wild-type strains. Nassar [129] also used artificial selection for 25 generations of adaptation of Pb2+ exposure and found increases in fecundity and longevity, as was the case for developmental exposure to low Pb2+ levels for one generation ([79,106] and see also [104]). On a genomic level, Ruden et al. [81] have assayed genome-wide transcription levels in 75 recombinant inbred Drosophila strains raised for one generation with and without lead, identifying over 1000 transcripts with altered expression in response to developmental lead exposure. This approach presents, for example, an opportunity to screen lead-dependent changes in transcription directly for individual loci known to be involved in endocrine regulation, to conduct unbiased screens for transcripts previously unassociated with lead metabolism, and to assay the same strains for lead-induced effects on endocrine-dependent traits that may be driven by the changes in transcription. Such genetical–genomic analysis [81] can be combined with systems genetics approaches [82] as a model for genetic regulation of complex traits and genetic correlations among them. Ayroles et al. [124] for example, have identified 241 “transcriptional modules” in Drosophila representing distinct complexes of transcripts, each of which is “enriched” for specific biological functions, allowing interactions among transcripts within modules and among modules to be mapped. This type of approach should be particularly useful for analysis of complex interactions among endocrine system components, traits that they regulate, and numerous environmental factors, and for distinguishing direct endocrine effects from those that may affect the same pathways indirectly through intersecting developmental, neural and metabolic mechanisms.

5. Evolutionary and life-history studies of lead toxicity Drosophila also provide a model system for evolution of life-history strategies, including endocrine-mediated regulation of trade-offs among life-span, fecundity and timing of reproduction [130], that could be employed to investigate population responses to environmental factors such as lead as well as their potential dependence on additional toxins and environmental factors such as temperature stress [131] and nutritional factors [125]. These types of studies can provide insights into potential long-term evolutionary and ecological impacts of environmental toxins such as Pb+ 2. For example, it might be useful to assay gene expression during artificial selection for lead resistance in control and selected lines after one generation of exposure, and again after multiple generations to determine whether initial lead-induced changes in the transcriptome predict long-term constitutive changes in gene expression in response to selection for adaptation to higher lead levels.

H.V.B. Hirsch et al. / Physiology & Behavior 99 (2010) 254–259

6. Summary Developmental Pb2+ exposure affects hormone-dependent behaviors in Drosophila, suggesting that Pb2+ is an endocrine disruptor in this species. We believe it is important, therefore, that experiments aimed at identifying the direct neural effects of Pb2+ take into consideration the possibility that Pb2+ may also alter behavior by modifying endocrine system function. Only then may we distinguish between separate pathways and mechanisms that are likely to play a role in the effects of this neurotoxin.

References [1] De Vleeschouwer F, Gerard L, Goormaghtigh C, Mattielli N, Le Roux G, Fagel N. Atmospheric lead and heavy metal pollution records from a Belgian peat bog spanning the last two millenia: human impact on a regional to global scale. Sci Total Environ 2007;377(2–3):282–95. [2] Caplun E, Petit D, Picciotto E. Lead in petrol. Endeavour 1984;8(3):135–44. [3] Lanphear BP, Dietrich KN, Berger O. Prevention of lead toxicity in US children. Ambul Pediatr 2003;3(1):27–36. [4] Iqbal S, Muntner P, Batuman V, Rabito FA. Estimated burden of blood lead levels 5 microg/dl in 1999–2002 and declines from 1988 to 1994. Environ Res 2008;107 (3):305–11. [5] Bellinger DC. Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr 2008;20(2):172–7. [6] White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 2007;225(1):1–27. [7] Woolf AD, Goldman R, Bellinger DC. Update on the clinical management of childhood lead poisoning. Pediatr Clin North Am 2007;54(2):271–94 viii. [8] Needleman H. Lead poisoning. Annu Rev Med 2004;55:209–22. [9] Nevin R, Jacobs DE, Berg M, Cohen J. Monetary benefits of preventing childhood lead poisoning with lead-safe window replacement. Environ Res 2008;106 (3):410–9. [10] Aschengrau A, Beiser A, Bellinger D, Copenhafer D, Weitzman M. The impact of soil lead abatement on urban children's blood lead levels: phase II results from the Boston Lead-In-Soil Demonstration Project. Environ Res 1994;67(2):125–48. [11] Clark HF, Brabander DJ, Erdil RM. Sources, sinks, and exposure pathways of lead in urban garden soil. J Environ Qual 2006;35(6):2066–74. [12] Clark CS, Rampal KG, Thuppil V, Chen CK, Clark R, Roda S. The lead content of currently available new residential paint in several Asian countries. Environ Res 2006;102(1):9–12. [13] Lin GZ, Peng RF, Chen Q, Wu ZG, Du L. Lead in housing paints: an exposure source still not taken seriously for children lead poisoning in China. Environ Res 2009;109(1):1–5. [14] Huo X, Peng L, Xu X, Zheng L, Qiu B, Qi Z, et al. Elevated blood lead levels of children in Guiyu, an electronic waste recycling town in China. Environ Health Perspect 2007;115(7):1113–7. [15] Hu H, Shih R, Rothenberg S, Schwartz BS. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 2007;115(3):455–62. [16] Nie H, Sanchez BN, Wilker E, Weisskopf MG, Schwartz J, Sparrow D, et al. Bone lead and endogenous exposure in an environmentally exposed elderly population: the normative aging study. J Occup Environ Med 2009;51(7):848–57. [17] Shih RA, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 2007;115(3):483–92. [18] Theppeang K, Glass TA, Bandeen-Roche K, Todd AC, Rohde CA, Schwartz BS. Gender and race/ethnicity differences in lead dose biomarkers. Am J Public Health 2008;98(7):1248–55. [19] Weuve J, Korrick SA, Weisskopf MA, Ryan LM, Schwartz J, Nie H, et al. Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect 2009;117(4):574–80. [20] Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, et al. Recommendations for medical management of adult lead exposure. Environ Health Perspect 2007;115(3):463–71. [21] Perlstein T, Weuve J, Schwartz J, Sparrow D, Wright R, Litonjua A, et al. Cumulative community-level lead exposure and pulse pressure: the normative aging study. Environ Health Perspect 2007;115(12):1696–700. [22] Gulson BL, Mizon KJ, Korsch MJ, Palmer JM, Donnelly JB. Mobilization of lead from human bone tissue during pregnancy and lactation—a summary of long-term research. Sci Total Environ 2003;303(1–2):79–104. [23] Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics 1992;90 (6):855–61. [24] Canfield RL, Henderson Jr CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 2003;348(16):1517–26. [25] Jusko TA, Henderson CR, Lanphear BP, Cory-Slechta DA, Parsons PJ, Canfield RL. Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age. Environ Health Perspect 2008;116(2):243–8.

257

[26] Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. Lowlevel environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005;113(7):894–9. [27] Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med 1990;322(2):83–8. [28] Nevin R. Trends in preschool lead exposure, mental retardation, and scholastic achievement: association or causation? Environ Res 2009;109(3):301–10. [29] Surkan PJ, Zhang A, Trachtenberg F, Daniel DB, McKinlay S, Bellinger DC. Neuropsychological function in children with blood lead levels < 10 microg/dL. Neurotoxicology 2007;28(6):1170–7. [30] Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL. Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 2001;23(6):511–8. [31] Nevin R. Understanding international crime trends: the legacy of preschool lead exposure. Environ Res 2007;104(3):315–36. [32] Wright JP, Dietrich KN, Ris MD, Hornung RW, Wessel SD, Lanphear BP, et al. Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Med 2008;5(5):e101. [33] Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006;114(12):1904–9. [34] Padich RA, Dietrich KN, Pearson DT. Attention, activity level, and lead exposure at 18 months. Environ Res 1985;38(1):137–43. [35] Altmann L, Sveinsson K, Kramer U, Weishoff-Houben M, Turfeld M, Winneke G, et al. Visual functions in 6-year-old children in relation to lead and mercury levels. Neurotoxicol Teratol 1998;20(1):9–17. [36] Buchanan LH, Counter SA, Ortega F, Laurell G. Distortion product oto-acoustic emissions in Andean children and adults with chronic lead intoxication. Acta Otolaryngol 1999;119(6):652–8. [37] Counter SA, Vahter M, Laurell G, Buchanan LH, Ortega F, Skerfving S. High lead exposure and auditory sensory–neural function in Andean children. Environ Health Perspect 1997;105(5):522–6. [38] Jones LG, Prins J, Park S, Walton JP, Luebke AE, Lurie DI. Lead exposure during development results in increased neurofilament phosphorylation, neuritic beading, and temporal processing deficits within the murine auditory brainstem. J Comp Neurol 2008;506(6):1003–17. [39] Lengyel Z, Lukacs A, Szabo A, Institoris L. Neurotoxic and general effects of combined subchronic exposure of rats to insecticides and heavy metals. Acta Biol Hung 2006;57(4):423–32. [40] Liang GH, Jarlebark L, Ulfendahl M, Bian JT, Moore EJ. Lead (Pb2+) modulation of potassium currents of guinea pig outer hair cells. Neurotoxicol Teratol 2004;26 (2):253–60. [41] Cory-Slechta DA, Pokora MJ. Lead-induced changes in muscarinic cholinergic sensitivity. Neurotoxicology 1995;16(2):337–47. [42] Tang M, Luo L, Zhu D, Wang M, Luo Y, Wang H, et al. Muscarinic cholinergic modulation of synaptic transmission and plasticity in rat hippocampus following chronic lead exposure. Naunyn Schmiedebergs Arch Pharmacol 2009;379 (1):37–45. [43] Wang L, Luo L, Luo YY, Gu Y, Ruan DY. Effects of Pb2+ on muscarinic modulation of glutamatergic synaptic transmission in rat hippocampal CA1 area. Neurotoxicology 2007;28(3):499–507. [44] Gilbert ME, Lasley SM. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo. Neurotoxicol Teratol 2007;29(3):385–93. [45] Guilarte TR. Pb2+ inhibits NMDA receptor function at high and low affinity sites: developmental and regional brain expression. Neurotoxicology 1997;18(1):43–51. [46] Yan D, Wang L, Ma FL, Deng H, Liu J, Li C, et al. Developmental exposure to lead causes inherent changes on voltage-gated sodium channels in rat hippocampal CA1 neurons. Neuroscience 2008;153(2):436–45. [47] Audesirk G, Audesirk T. Effects of in vitro lead exposure on voltage-sensitive calcium channels differ among cell types in central neurons of Lymnaea stagnalis. Neurotoxicology 1989;10(4):659–69. [48] Busselberg D. Calcium channels as target sites of heavy metals. Toxicol Lett 1995;82–83:255–61. [49] Sandhir R, Gill KD. Alterations in calcium homeostasis on lead exposure in rat synaptosomes. Mol Cell Biochem 1994;131(1):25–33. [50] Suszkiw JB. Presynaptic disruption of transmitter release by lead. Neurotoxicology 2004;25(4):599–604. [51] Vazquez A, Pena de Ortiz S. Lead (Pb(+ 2)) impairs long-term memory and blocks learning-induced increases in hippocampal protein kinase C activity. Toxicol Appl Pharmacol 2004;200(1):27–39. [52] Zhang HS, Song LH, Wang L, Qin YH. Lead can inhibit NMDA-, K(+)-, QA/KAinduced increases in intracellular free Ca2+ in cultured rat hippocampal neurons. Biomed Environ Sci 2002;15(4):330–40. [53] He T, Singh V, Hirsch HVB, Ruden DM, Lnenicka GA. Chronic lead exposure alters calcium regulation at presynaptic terminals in Drosophila larvae. Neurotoxicology in press. Available online 2 September 2009. [54] Denham M, Schell LM, Deane G, Gallo MV, Ravenscroft J, DeCaprio AP. Relationship of lead, mercury, mirex, dichlorodiphenyldichloroethylene, hexachlorobenzene, and polychlorinated biphenyls to timing of menarche among Akwesasne Mohawk girls. Pediatrics 2005;115(2):e127–34. [55] Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens A, Bethel J. Blood lead concentration and delayed puberty in girls. N Engl J Med 2003;348 (16):1527–36. [56] Staessen JA, Nawrot T, Hond ED, Thijs L, Fagard R, Hoppenbrouwers K, et al. Renal function, cytogenetic measurements, and sexual development in adolescents in

258

[57]

[58]

[59] [60]

[61]

[62]

[63]

[64]

[65] [66] [67]

[68] [69] [70]

[71] [72] [73] [74]

[75]

[76] [77] [78] [79]

[80]

[81]

[82]

[83]

[84]

[85]

[86] [87]

H.V.B. Hirsch et al. / Physiology & Behavior 99 (2010) 254–259 relation to environmental pollutants: a feasibility study of biomarkers. Lancet 2001;357(9269):1660–9. Wu T, Buck GM, Mendola P. Blood lead levels and sexual maturation in U.S. girls: the Third National Health and Nutrition Examination Survey, 1988–1994. Environ Health Perspect 2003;111(5):737–41. Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, et al. Environmental exposures and puberty in inner-city girls. Environ Res 2008;107 (3):393–400. Winder C. Lead, reproduction and development. Neurotoxicology 1993;14(2– 3):303–17. Bonde JP, Joffe M, Apostoli P, Dale A, Kiss P, Spano M, et al. Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels. Occup Environ Med 2002;59(4):234–42. Gennart JP, Buchet JP, Roels H, Ghyselen P, Ceulemans E, Lauwerys R. Fertility of male workers exposed to cadmium, lead, or manganese. Am J Epidemiol 1992;135 (11):1208–19. Hsu PC, Chang HY, Guo YL, Liu YC, Shih TS. Effect of smoking on blood lead levels in workers and role of reactive oxygen species in lead-induced sperm chromatin DNA damage. Fertil Steril 2009;91(4):1096–103. Kasperczyk A, Kasperczyk S, Horak S, Ostalowska A, Grucka-Mamczar E, Romuk E, et al. Assessment of semen function and lipid peroxidation among lead exposed men. Toxicol Appl Pharmacol 2008;228(3):378–84. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007;87 (3):905–31. McCarthy MM. Estradiol and the developing brain. Physiol Rev 2008;88 (1):91–124. Mermelstein PG, Micevych PE. Nervous system physiology regulated by membrane estrogen receptors. Rev Neurosci 2008;19(6):413–24. Micevych PE, Mermelstein PG. Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain. Mol Neurobiol 2008;38(1):66–77. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 1997;387(2):167–78. Cooper GP, Manalis RS. Influence of heavy metals on synaptic transmission: a review. Neurotoxicology 1983;4(4):69–83. Morley EJ, Hirsch HV, Hollocher K, Lnenicka GA. Effects of chronic lead exposure on the neuromuscular junction in Drosophila larvae. Neurotoxicology 2003;24 (1):35–41. Toscano CD, Guilarte TR. Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev 2005;49(3):529–54. Schantz SL, Widholm JJ. Cognitive effects of endocrine-disrupting chemicals in animals. Environ Health Perspect 2001;109(12):1197–206. Crews D, Willingham E, Skipper JK. Endocrine disruptors: present issues, future directions. Q Rev Biol 2000;75(3):243–60. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009;30(4):293–342. Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, Ankley GT, et al. Fifteen years after “Wingspread”—environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci 2008;105(2):235–59. McLachlan JA. Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 2001;22(3):319–41. Witorsch RJ. Endocrine disruptors: can biological effects and environmental risks be predicted? Regul Toxicol Pharmacol 2002;36(1):118–30. Iavicoli I, Fontana L, Bergamaschi A. The effects of metals as endocrine disruptors. J Toxicol Environ Health B Crit Rev 2009;12(3):206–23. Hirsch HV, Mercer J, Sambaziotis H, Huber M, Stark DT, Torno-Morley T, et al. Behavioral effects of chronic exposure to low levels of lead in Drosophila melanogaster. Neurotoxicology 2003;24(3):435–42. Hirsch HV, Possidente D, Averill S, Despain TP, Buytkins J, Thomas V, et al. Variations at a quantitative trait locus (QTL) affect development of behavior in lead-exposed Drosophila melanogaster. Neurotoxicology 2009;30(2):305–11. Ruden DM, Chen L, Possidente D, Possidente B, Rasouli P, Wang L, et al. Genetical toxicogenomics in Drosophila identifies master modulatory loci that are regulated by developmental exposure to lead. Neurotoxicology 2009;30:898–914. Yepiskoposyan H, Egli D, Fergestad T, Selvaraj A, Treiber C, Multhaup G, et al. Transcriptome response to heavy metal stress in Drosophila reveals a new zinc transporter that confers resistance to zinc. Nucleic Acids Res 2006;34 (17):4866–77. Akins JM, Schroeder JA, Brower DL, Aposhian HV. Evaluation of Drosophila melanogaster as an alternative animal for studying the neurotoxicity of heavy metals. Biometals 1992;5(2):111–20. Balamurugan K, Hua H, Georgiev O, Schaffner W. Mercury and cadmium trigger expression of the copper importer Ctr1B, which enables Drosophila to thrive on heavy metal-loaded food. Biol Chem 2009;390(2):109–13. Lauverjat S, Ballan-Dufrancais C, Wegnez M. Detoxification of cadmium. Ultrastructural study and electron-probe microanalysis of the midgut in a cadmium-resistant strain of Drosophila melanogaster. Biol Met 1989;2 (2):97–107. Rand MD, Dao JC, Clason TA. Methylmercury disruption of embryonic neural development in Drosophila. Neurotoxicology 2009;30:794–802. deFur PL. Use and role of invertebrate models in endocrine disruptor research and testing. Ilar J 2004;45(4):484–93.

[88] Riddiford LM. Hormones and Drosophila development. In: Bate M, Arias A, editors. The development of Drosophila melanogaster. Cold Spring Harbor, New York USA: Cold Spring Harbor Laboratory Press; 1993. p. 899–939. [89] Bardet PL, Laudet V, Vanacker JM. Studying non-mammalian models? Not a fool's ERRand! Trends Endocrinol Metab 2006;17(4):166–71. [90] King-Jones K, Thummel CS. Nuclear receptors—a perspective from Drosophila. Nat Rev Genet 2005;6(4):311–23. [91] Flatt T, Kawecki TJ. Pleiotropic effects of methoprene-tolerant (Met), a gene involved in juvenile hormone metabolism, on life history traits in Drosophila melanogaster. Genetica 2004;122(2):141–60. [92] Liu Z, Li X, Prasifka JR, Jurenka R, Bonning BC. Overexpression of Drosophila juvenile hormone esterase binding protein results in anti-JH effects and reduced pheromone abundance. Gen Comp Endocrinol 2008;156(1):164–72. [93] Belgacem YH, Martin JR. Neuroendocrine control of a sexually dimorphic behavior by a few neurons of the pars intercerebralis in Drosophila. Proc Natl Acad Sci U S A 2002;99(23):15154–8. [94] Meunier N, Belgacem YH, Martin JR. Regulation of feeding behaviour and locomotor activity by takeout in Drosophila. J Exp Biol 2007;210(Pt 8):1424–34. [95] Wilson TG, DeMoor S, Lei J. Juvenile hormone involvement in Drosophila melanogaster male reproduction as suggested by the Methoprene-tolerant (27) mutant phenotype. Insect Biochem Mol Biol 2003;33(12):1167–75. [96] Christopherson KS, Mark MR, Bajaj V, Godowski PJ. Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci U S A 1992;89(14):6314–8. [97] Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6(3):517–26. [98] Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000;6(3):507–15. [99] Marvin KA, Reinking JL, Lee AJ, Pardee K, Krause HM, Burstyn JN. Nuclear receptors homo sapiens Rev-erbbeta and Drosophila melanogaster E75 are thiolate-ligated heme proteins which undergo redox-mediated ligand switching and bind CO and NO. Biochemistry 2009;48(29):7056–71. [100] Ostberg T, Jacobsson M, Attersand A, Mata de Urquiza A, Jendeberg L. A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity. Biochemistry 2003;42(21):6427–35. [101] Palanker L, Necakov AS, Sampson HM, Ni R, Hu C, Thummel CS, et al. Dynamic regulation of Drosophila nuclear receptor activity in vivo. Development 2006;133 (18):3549–62. [102] Pardee K, Reinking J, Krause H. Nuclear hormone receptors, metabolism, and aging: what goes around comes around. Transcription factors link lipid metabolism and aging-related processes. Sci Aging Knowledge Environ 2004;2004(47):re8. [103] Thackray VG, Young RH, Hooper JE, Nordeen SK. Estrogen agonist and antagonist action on the human estrogen receptor in Drosophila. Endocrinology 2000;141 (10):3912–5. [104] Bajraktari ISG, Marinkovic D, Hajrizi A. The influence of heavy metals on the duration of Drosophila melanogaster preadult development. Acta Biol Med Exp 1987;12:57–66. [105] Cohn J, Widzowski DV, Cory-Slechta DA. Lead retards development of Drosophila melanogaster. Comp Biochem Physiol C 1992;102(1):45–9. [106] Massie HR, Aiello VR, Whitney SJP. Lead accumulation during aging of Drosophila and effect of dietary lead on life span. Age 1992;15:47–9. [107] Uysal H, Bahceci Z. Effect of lead acetate and mercury chloride on offspring production in Drosophila melanogaster. Drosoph Inf Serv July 1996;77:102–3. [108] Calabrese EJ, Baldwin LA. Hormesis: the dose–response revolution. Annu Rev Pharmacol Toxicol 2003;43:175–97. [109] Nuzhdin SV, Pasyukova EG, Dilda CL, Zeng ZB, Mackay TF. Sex-specific quantitative trait loci affecting longevity in Drosophila melanogaster. Proc Natl Acad Sci U S A 1997;94(18):9734–9. [110] Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000;29(10):927–45. [111] Wills ED. Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation unsaturated fatty acids. Biochim Biophys Acta 1965;98:238–51. [112] Yiin SJ, Lin TH. Lead-catalyzed peroxidation of essential unsaturated fatty acid. Biol Trace Elem Res 1995;50(2):167–72. [113] Gerber G, Maes J, Deroo J. Effect of dietary lead on placental blood flow and on fetal uptake of alpha-amino isobutyrate. Arch Toxicol 1978;41(2):125–31. [114] Sandhir R, Julka D, Gill KD. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol Toxicol 1994;74(2):66–71. [115] Shafiq Ur R. Lead-induced regional lipid peroxidation in brain. Toxicol Lett 1984;21(3):333–7. [116] Shafiq ur R, Chandra O. Regional interrelationships of zinc, copper, and lead in the brain following lead intoxication. Bull Environ Contam Toxicol 1984;32 (2):157–65. [117] Drysdale R. FlyBase: a database for the Drosophila research community. Methods Mol Biol 2008;420:45–59. [118] Li H, Cooper RL. Effects of the ecdysoneless mutant on synaptic efficacy and structure at the neuromuscular junction in Drosophila larvae during normal and prolonged development. Neuroscience 2001;106(1):193–200. [119] Lai CQ, Parnell LD, Lyman RF, Ordovas JM, Mackay TF. Candidate genes affecting Drosophila life span identified by integrating microarray gene expression analysis and QTL mapping. Mech Ageing Dev 2007;128(3):237–49.

H.V.B. Hirsch et al. / Physiology & Behavior 99 (2010) 254–259 [120] Lai CQ, Leips J, Zou W, Roberts JF, Wollenberg KR, Parnell LD, et al. Speed-mapping quantitative trait loci using microarrays. Nat Methods 2007;4(10):839–41. [121] Mackay TF, Anholt RR. Of flies and man: Drosophila as a model for human complex traits. Annu Rev Genomics Hum Genet 2006;7:339–67. [122] Takahashi JS, Shimomura K, Kumar V. Searching for genes underlying behavior: lessons from circadian rhythms. Science 2008;322(5903):909–12. [123] Hooven LA, Sherman KA, Butcher S, Giebultowicz JM. Does the clock make the poison? Circadian variation in response to pesticides. PLoS One 2009;4(7):e6469. [124] Ayroles JF, Carbone MA, Stone EA, Jordan KW, Lyman RF, Magwire MM, et al. Systems genetics of complex traits in Drosophila melanogaster. Nat Genet 2009;41(3):299–307. [125] Ruden DM, Lu X. Evolutionary conservation of metabolism explains how Drosophila nutrigenomics can help us understand human nutrigenomics. Genes Nutr 2006;1(2):75–83. [126] Ruden DM. Personalized medicine and quantitative trait transcripts. Nat Genet 2007;39(2):144–5.

259

[127] Dinan L, Bourne P, Whiting P, Dhadialla TS, Hutchinson TH. Screening of environmental contaminants for ecdysteroid agonist and antagonist activity using the Drosophila melanogaster B(II) cell in vitro assay. Environ Toxicol Chem 2001;20(9):2038–46. [128] Magnusson J, Ramel C. Genetic variation in the susceptibility to mercury and other metal compounds in Drosophila melanogaster. Teratog Carcinog Mutagen 1986;6(4):289–305. [129] Nassar R. Genetics of resistance to tetraethyllead. Aust J Biol Sci 1979;32 (1):127–32. [130] Flatt T, Kawecki TJ. Juvenile hormone as a regulator of the trade-off between reproduction and life span in Drosophila melanogaster. Evolution 2007;61 (8):1980–91. [131] Morgan TJ, Mackay TF. Quantitative trait loci for thermotolerance phenotypes in Drosophila melanogaster. Heredity 2006;96(3):232–42.